JP Morgan Chase
RMD icon

JP Morgan Chase’s ResMed RMD Stock Holding History

JP Morgan Chase’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Sell
5,000
-5,600
-53% -$1.4M ﹤0.01% 4551
2025
Q4 		$2.55M Buy
10,600
+5,600
+112% +$1.43M ﹤0.01% 3895
2025
Q3 		$1.37M Sell
5,000
-500
-9% -$137K ﹤0.01% 4356
2025
Q2 		$1.42M Buy
5,500
+500
+10% +$119K ﹤0.01% 4154
2025
Q1 		$1.12M Sell
5,000
-300
-6% -$70K ﹤0.01% 4262
2024
Q4 		$1.21M Sell
5,300
-12,800
-71% -$3.08M ﹤0.01% 4487
2024
Q3 		$4.42M Buy
18,100
+16,600
+1,107% +$3.71M ﹤0.01% 3304
2024
Q2 		$287K Buy
1,500
+300
+25% +$60.9K ﹤0.01% 4958
2024
Q1 		$238K Sell
1,200
-3,200
-73% -$586K ﹤0.01% 5256
2023
Q4 		$757K Hold
4,400
– – ﹤0.01% 4522
2023
Q3 		$651K Buy
+4,400
New +$796K ﹤0.01% 4335
2021
Q1 		– Sell
-20,700
Closed -$4.4M – 6307
2020
Q4 		$4.4M Buy
+20,700
New +$4.13M ﹤0.01% 2913
2014
Q4 		– Sell
-755,000
Closed -$37.2M – 4334
2014
Q3 		$37.2M Buy
+755,000
New +$38.5M 0.01% 1074

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase's RMD Position: Q1 2026 in Review

JP Morgan Chase increased its ResMed (RMD) stake by 20% in Q1 2026, buying an estimated $29.8M and bringing the position to 705,147 shares worth $155M. The position accounts for 0.01% of the portfolio, ranked #797.

JP Morgan Chase first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $306M in Q4 2020. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • JP Morgan Chase held 705,147 shares of ResMed worth $155M as of Q1 2026.
  • JP Morgan Chase bought 119,539 ResMed shares in Q1 2026, an estimated $29.8M.
  • ResMed made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #797 holding.
  • JP Morgan Chase first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's ResMed position peaked at $306M in Q4 2020.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.